Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 810Uterine Cervical Neoplasms 545Endometrial Neoplasms 466Breast Neoplasms 223Fallopian Tube Neoplasms 202Colorectal Neoplasms 181Carcinoma, Non-Small-Cell Lung 163Neoplasms 139Stomach Neoplasms 128Pancreatic Neoplasms 119Prostatic Neoplasms 108Neoplasm Metastasis 107Melanoma 107Lung Neoplasms 104Carcinoma, Ovarian Epithelial 94Triple Negative Breast Neoplasms 91Squamous Cell Carcinoma of Head and Neck 82Esophageal Neoplasms 78Head and Neck Neoplasms 76Urinary Bladder Neoplasms 75Carcinoma, Renal Cell 75Uterine Neoplasms 66Vulvar Neoplasms 65Uterine Cervical Dysplasia 59Peritoneal Neoplasms 59Colonic Neoplasms 59Carcinoma, Hepatocellular 58Sarcoma 53Carcinoma, Transitional Cell 48Papillomavirus Infections 47

Interventions

camrelizumab 1Surgical Procedures, Operative 1Paclitaxel 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrioid Endometrial Cancer × Gynecologic × 1 year × Clear all
NCT06561308 2025-12-01

Clinical Efficacy Study of PD-1 Inhibitor Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Women's Hospital School Of Medicine Zhejiang University

Phase 2 Recruiting
39 enrolled
Gynecologic

Endometrioid Endometrial Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡